The transgenic rabbit as model for human diseases and as a source of biologically active recombinant proteins.
Until recently, transgenic rabbits were produced exclusively by pronuclear microinjection which results in additive random insertional transgenesis; however, progress in somatic cell cloning based on nuclear transfer will soon make it possible to produce rabbits with modifications to specific genes by the combination of homologous recombination and subsequent prescreening of nuclear donor cells. Transgenic rabbits have been found to be excellent animal models for inherited and acquired human diseases including hypertrophic cardiomyopathy, perturbed lipoprotein metabolism and atherosclerosis. Transgenic rabbits have also proved to be suitable bioreactors for the production of recombinant protein both on an experimental and a commercial scale. This review summarizes recent research based on the transgenic rabbit model.
Bosze
Zs
Z
Department of Animal Biology, Agricultural Biotechnology Center Gödöllo, Hungary. bosze@abc.hu
Hiripi
L
L
Carnwath
J W
JW
Niemann
H
H
D000818:Animals; D030801:Animals, Genetically Modified; D004195:Disease Models, Animal; D005260:Female; D018014:Gene Transfer Techniques; D006728:Hormones / Q000235:genetics / Q000378:metabolism; D008321:Mammary Glands, Animal / Q000378:metabolism; D010455:Peptides / Q000235:genetics / Q000378:metabolism; D011817:Rabbits / Q000235:genetics*
D006728:Hormones; D010455:Peptides